Newly published hypothesis article outlines why (Z)-endoxifen may matter in DMDThe article about (Z)- Endoxifen in Duchenne Muscular Dystrophy (DMD), surveys the DMD treatment landscape and details how (Z)-endoxifen's pharmacology could address multiple downstream drivers of disease, including inflammation, fibrosis, calcium dysregulation, mitochondrial dysfunction, and lipid abnormalities. A video abstract of the paper can be found here. Accessibility StatementSkip Navigation Published article outlines rat ...